01 10Sutent
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 936
2018 Revenue in Millions : 1,049
Growth (%) : -11
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 819
2019 Revenue in Millions : 936
Growth (%) : -13
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 673
2020 Revenue in Millions : 819
Growth (%) : -18
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 347
2021 Revenue in Millions : 673
Growth (%) : -48
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 180
2022 Revenue in Millions : 347
Growth (%) : -48
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -2.40%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 1,174
2014 Revenue in Millions : 1,120
Growth (%) : -5%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 1,095
2015 Revenue in Millions : 1,120
Growth (%) : -2
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 1,081
2016 Revenue in Millions : 1,096
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 1,049
2017 Revenue in Millions : 1,081
Growth (%) : -3%
LOOKING FOR A SUPPLIER?